Status: Recruiting
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linezolid (IV and PO) administered for a total of 14 to 28 days in adult subjects with moderate or severe DFI.
Participants needed: 865
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: MicuRxUpdated: Sep 10, 2025Locations: 14
Eligibility criteria
Have diabetes mellitus (type 1 or 2) per the American Diabetes Association crite... [+3]
Previous DFI known or suspected to be caused by Gram-positive pathogens that are... [+6]